International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 5 of the 68 sources its claims cite were checked for support.
Abstract
In the accompanying comment letter (1), Weinert summarizes published data from the Brazilian Gestational Diabetes Study (2) and comments on applying International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel recommendations (3) for the diagnosis of gestational diabetes mellitus (GDM) to that cohort. The Brazilian study provided evidence that adverse perinatal outcomes are associated with levels of maternal glycemia below those diagnostic of GDM by American Diabetes Association or World Health Organization criteria. However, the results were potentially confounded by the treatment of GDM. It did find that women with GDM were at increased risk for some …
Overview
CoChat Summary
## TL;DR
This IADPSG consensus report recommends new gestational diabetes mellitus (GDM) diagnostic thresholds based on HAPO study data, using a 75-g OGTT and outcome-linked glucose cutoffs. It also recommends early detection of overt diabetes in pregnancy and notes that these recommendations will increase the frequency of diagnosed hyperglycemic disorders in pregnancy.
## Key findings
- In the HAPO study, a 75-g OGTT was performed in a heterogeneous, multinational, multicultural, ethnically diverse cohort of approximately 25,000 women in the third trimester; medical caregivers were blinded unless predefined glucose criteria were exceeded.
- The report states that the HAPO data showed continuous, graded associations between maternal glucose and primary outcomes, with no obvious thresholds; associations were also observed for secondary outcomes and did not differ among centers.
- The recommended diagnostic thresholds correspond to glucose levels where odds for birth weight >90th percentile, cord C-peptide >90th percentile, and percent body fat >90th percentile reached 1.75 times the estimated odds at mean glucose values; by these criteria, FPG alone identified 8.3% of the HAPO cohort, FPG plus 1-hour glucose identified an additional 5.7%, and 2-hour glucose another 2.1%, for a total GDM incidence of 17.8%.
- Among the HAPO cohort, 11.1% had only one elevated result, 3.9% had two elevated results, 1.1% had all three elevated, and 1.7% were unblinded because FPG or 2-hour glucose exceeded 5.8 mmol/l (105 mg/dl) or 11.1 mmol/l (200 mg/dl).
## Methods
- Consensus report based on review of the HAPO study, additional unpublished HAPO findings, and other published studies discussed at a June 2008 IADPSG workshop/meeting in Pasadena, followed by consensus panel deliberation.
- HAPO design described as observational: a 75-g OGTT in a large multinational cohort, with blinded caregivers except for preset safety thresholds.
- Thresholds were derived from fully adjusted logistic regression models relating continuous maternal glucose measures (FPG, 1-hour, 2-hour) to outcomes; the panel selected an odds ratio threshold of 1.75 relative to mean glucose values.
## Limitations
- The paper states that recommendations for detecting overt diabetes during pregnancy are based on the opinions of the IADPSG Consensus Panel because prospective studies or appropriately designed clinical trials were not available.
- It states that it was not determined whether universal early testing for overt diabetes is clinically valuable or cost-effective.
- Evident from the text: the HAPO study was observational, not a clinical trial, so the diagnostic thresholds are inferred from associations rather than randomized intervention effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 0 Not valid · 36 Not checked · 22 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Similar associations were also observed for secondary outcomes (25,26).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
The Abstract of our copy states that the predefined primary outcomes (size at birth, cesarean delivery, neonatal hypoglycemia, fetal hyperinsulinemia) were reported elsewhere, and that this report's goals were to examine maternal glycemia against additional/newborn anthropometric outcomes (sum of skin folds, individual skin folds, percent body fat) plus cord C-peptide. The Results report strong, graded, continuous associations for these outcomes (e.g., ORs 1.33–1.47 for percent body fat >90th percentile and 1.28–1.56 for individual skin folds), and the Discussion explicitly says 'This pattern is similar to that reported for maternal glucose and birth weight >90th percentile.' That covers the claim's substance — similar associations for the secondary/additional outcomes — even though the paper does not use the label 'secondary outcomes'. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Associations of LGA and excess adiposity with fetal hyperinsulinemia are strong and independent of confounders (26,37,38).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
What the sources say
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
In the Results (Table 5), higher cord C-peptide, the paper’s measure of fetal insulin, is strongly associated with birth weight above the 90th percentile and adiposity measures. The Discussion states that the relationships persisted after adjustment for potential confounders. The paper does not claim that every possible confounder was excluded. (LLM, conf=0.92)
- Not checked yetcites [37] Metzger BE Silverman BL Freinkel N Dooley SL Ogata ES Green OC: Amniotic fluid insulin concentration as a predictor of obesity. Arch Dis Child 1990; 65: 1050– 1052 2241225 PMC1590256 source
- Not checked yetcites [38] Weiss PA Haeusler M Tamussino K Haas J: Can glucose tolerance test predict fetal hyperinsulinism? BJOG 2000; 107: 1480– 1485 11192103 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Although not directly comparable, it was concluded that results of the two randomized controlled trials (47,48) and HAPO (25,26) are highly complementary.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM > Other considerations
What the sources say
- Supportedcites [47] Crowther CA Hiller JE Moss JR McPhee AJ Jeffries WS Robinson JS: Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477– 2486 15951574 source
The paper identifies itself as a randomized clinical trial and reports its treatment results (secondary outcomes; page unavailable). In the citing sentence, this citation identifies one of the two trials whose results are being discussed; it does not attribute the cross-study judgment of complementarity to this trial paper. (LLM, conf=0.88)
- Not checked yetcites [48] Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B Wapner RJ Varner MW Rouse DJ Thorp JM Jr Sciscione A Catalano P Harper M Saade G Lain KY Sorokin Y Peaceman AM Tolosa JE Anderson GB: Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009: 361; 1339– 1348. PMC2804874 19797280
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Could not verifycites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 sourceExperimental — accuracy not yet measured
The Abstract reports HAPO findings on maternal glucose and pregnancy outcomes, but does not compare them with randomized trials. Searches for randomized trials and for the claimed complementarity found no passage in our copy making that comparison. No page numbers were available. (LLM, conf=0.70)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“Importantly, there were continuous graded relationships between higher maternal glucose and increasing frequency of the primary outcomes, independent of other risk factors (25).”
- Also stated in: § Future considerations · boosted
“The HAPO study was a basic epidemiological investigation that for the first time conclusively identified strong continuous associations of maternal glucose levels below those diagnostic of diabetes with several perinatal outcomes.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Future considerations · boosted
None of the sources cited for this claim have been checked yet.
In the paper
“HAPO data show strong linear associations of risks for >90th percentiles of birth weight, cord C-peptide, and percent body fat with each of three measures of maternal glucose (FPG, 1-h, and 2-h post–75-g load).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 62 claims and to verify the 63 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GDM was identified when fasting blood glucose (FBG) ≥ 5.1 mmol/L during the first trimester or any plasma glucose after a 75 g OGTT performed as: FBG ≥ 5.1 mmol/L, 1 h after glucose load ≥ 10.0 mmol/L or 2 h after glucose load ≥ 8.5 mmol/L using the criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) [28].”
From Associations of maternal pre-pregnancy BMI and gestational weight gain with the risks of adverse pregnancy outcomes in Chinese women with gestational diabetes mellitus (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“to adopt diagnostic glucose thresholds corresponding to a HAPO OR of 1.75 (fasting plasma glucose [FPG] 5.1–6.9 mmol/L, one‐hour plasma glucose [1hPG] ≥ 10.0 mmol/L, and/or two‐hour plasma glucose [2hPG] 8.5–11.0 mmol/L). 14”
From Australasian Diabetes in Pregnancy Society ( ADIPS ) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes (2025) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The IADPSG diagnostic thresholds are the first criteria based on risks of adverse perinatal outcomes, rather than risk of subsequent development of maternal diabetes1 or by applying thresholds that define impaired glucose tolerance outside of pregnancy.5,6”
From Gestational Diabetes Mellitus (2019) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“following the diagnostic criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) (18)”
From Diabetes gestacional y riesgo de apnea obstructiva del sueño en el tercer trimestre (2025) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Based on the HAPO Study and other studies, new criteria for the diagnosis of gestational diabetes were proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) 2 and adopted by the World Health Organization and others.3,4”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [2]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303 · cited 2×
“Long-term risks associated with fetal macrosomia in infants of women with GDM (independent of confounders) include childhood overweight (43,44) and metabolic factors that may increase risk of cardiovascular disease (CVD) (45).”
BackgroundA Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
(1964) · PubMed · Cited by 1,230
Research works printed but not linked: 2
- Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Health Canada 1994; 15– 23
- National Collaborating Centre for Women's and Children's Health. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London, U.K., RCOG Press, 2008 21370515
Cited by
Items 501–600 of 1,132
Screening and Diagnosis of Gestational Diabetes Mellitus
Kalter-Leibovici, O., Freedman, L. S., Olmer, L., Liebermann, N., Heymann, A., Tal, O., Lerner-Geva, L., Melamed, N., & Hod, M. (2012) · Diabetes Care · doi:10.2337/dc12-0041 · Cited by 70
Early Prediction of Gestational Diabetes Mellitus in Vietnam
Tran, T. S., Hirst, J. E., Do, M. A. T., Morris, J. M., & Jeffery, H. E. (2013) · Diabetes Care · doi:10.2337/dc12-1418 · Cited by 70
“The rates of GDM by the new IADPSG criteria in Asian populations have been found to be very close to ours, with a GDM prevalence using these criteria of 23.0% in Thailand and 25.1% in Singapore (27).”
BackgroundMethodInfluentialMaraschin, J. D. F. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_2 · Cited by 89
Zhao, X. Y., Gang, X., Liu, Y., Sun, C., Han, Q., & Wang, G. (2016) · Journal of Diabetes Research · doi:10.1155/2016/8160545 · Cited by 78
Shang, M., Dong, X., & Hou, L. (2018) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.13586 · Cited by 70
“risk of developing type 2 diabetes or some formula equation.(5) Our previous study also confirmed that the”
MethodResultSimmons, D., Hague, W. M., Teede, H. J., Cheung, N. W., Hibbert, E. J., Nolan, C. J., Peek, M. J., Girosi, F., Cowell, C. T., Wong, V. W., et al. (2018) · Medical Journal of Australia · doi:10.5694/mja17.01129 · Cited by 67
Retnakaran, R. R., & Shah, B. R. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30077-4 · Cited by 72
Sargin, M. A., Yassa, M., Taymur, B. D., CELIK, A., Ergun, E., & Tuğ, N. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s104247 · Cited by 85
Tang, L., Li, P., & Li, L. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13250 · Cited by 75
Gut Microbiome Changes in Gestational Diabetes
Ionescu, R. F., Enache, R. M., Creţoiu, S. M., & Gașpar, B. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112839 · Cited by 73
Syngelaki, A., Visser, G. H. A., Krithinakis, K., Wright, A., & Nicolaides, K. H. (2015) · Metabolism · doi:10.1016/j.metabol.2015.10.029 · Cited by 76
“[54] Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al.”
BackgroundRisk factors and outcomes of macrosomia in China: a multicentric survey based on birth data
Wang, D., Hong, Y., Zhu, L., Wang, X., Lv, Q., Zhou, Q., Ruan, M., & Chen, C. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1252746 · Cited by 76
Dudzik, D., Żórawski, M., Skotnicki, M., Zarzycki, W., García, A., Angulo, S., Lorenzo, M. P., Barbas, C., & Ramos, P. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.02.056 · Cited by 75
Postpartum glucose intolerance: an updated overview
Pastore, I., CHIEFARI, E. D., Vero, R., & Brunetti, A. (2017) · Endocrine · doi:10.1007/s12020-017-1388-0 · Cited by 71
Li, J., Huo, X., Cao, Y., Li, S., Du, Z., Shao, P., Leng, J., Zhang, C., Sun, X., Ronald, C. W., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.08.015 · Cited by 74
Maternal lipid profile differs by gestational diabetes physiologic subtype
Layton, J. C., Powe, C. E., Allard, C., Battista, M., Doyon, M., Bouchard, L., Perron, P., Wessel, J., & Hivert, M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.11.008 · Cited by 71
Gestational Diabetes and Breastfeeding Outcomes: A Systematic Review
Nguyen, P. T. H., Pham, N. M., Chu, T. K., Duong, D., & Do, D. V. (2019) · Asia Pacific Journal of Public Health · doi:10.1177/1010539519833497 · Cited by 77
Holmes, V. A., Draffin, C. R., Patterson, C. C., Francis, L., Irwin, J., McConnell, M., Farrell, B., Brennan, S. F., McSorley, O., Wotherspoon, A. C., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02654 · Cited by 68
Evidenced-Based Nutrition for Gestational Diabetes Mellitus
Mahajan, A., Donovan, L. E., Vallee, R., & Yamamoto, J. M. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1208-4 · Cited by 68
Herrera, E., & Ortega-Senovilla, H. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0978-4 · Cited by 68
Ellerbrock, J., Spaanderman, B., van Drongelen, J., Mulder, E., van Balen, V. A. L., Schiffer, V. M. M. M., Jorissen, L. M., Alers, R., Leenen, J., Ghossein‐Doha, C., et al. (2022) · Nutrients · doi:10.3390/nu14122444 · Cited by 75
“GDM was diagnosed according to the International Association of Diabetes in Pregnancy Study Group (IADPSG) criteria [12].”
Sacks, D. A., Black, M. H., Li, X., Montoro, M. N., & Lawrence, J. M. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000865 · Cited by 66
Diagnosis of GDM: A suggested consensus
McIntyre, D. H., Colagiuri, S., Roglić, G., & Hod, M. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.04.022 · Cited by 77
Hoedjes, M., Berks, D., Vogel, I., Franx, A., Duvekot, J. J., Oenema, A., Steegers, E. A. P., & Raat, H. (2011) · Hypertension in Pregnancy · doi:10.3109/10641955.2010.544803 · Cited by 71
Gestational Diabetes Mellitus and Future Cardiovascular Risk: An Update
Burlina, S., Dalfra, M., Chilelli, N. C., & Lapolla, A. (2016) · International Journal of Endocrinology · doi:10.1155/2016/2070926 · Cited by 76
“[15] recently examined the prevalence of metabolic syndrome in women with a history of GDM according to the new criteria for the diagnosis of this condition [23].”
Rosta, K., Al-Aissa, Z., Hadarits, O., Harreiter, J., Nádasdi, Á., Kelemen, F., Bancher-Todesca, D., Komlósi, Z., Németh, L., Rigó, J., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0169781 · Cited by 67
The diagnosis of gestational diabetes mellitus: new paradigms or status quo?
The International Association of Diabetes & Pregnancy Study Groups (IADPSG) Consensus Panel Writing Group and the Hyperglycemia & Adverse Pregnancy Outcome (HAPO) Study Steering Committee (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.718002 · Cited by 68
Basri, N. I., Mahdy, Z. A., Ahmad, S., Abdul Karim, A. K., Shan, L. P., Abdul Manaf, M. R., & Ismail, N. A. M. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0077 · Cited by 64
Alptekin, H., Çizmecioğlu, A., Işık, H., Cengiz, T., Yildiz, M., & Iyisoy, M. S. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0427-z · Cited by 67
The Joint Associations of Maternal BMI and Glycemia with Childhood Adiposity
Josefson, J. L., Catalano, P. M., Lowe, W. L., Scholtens, D. M., Kuang, A., Dyer, A. R., Lowe, L. P., & Metzger, B. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa180 · Cited by 65
Tian, Y., Zhang, S., Huang, F., & Ma, L. (2021) · JMIR mhealth and uhealth · doi:10.2196/22881 · Cited by 69
Reyes-Muñoz, E., Parra, A., Castillo-Mora, A., & Ortega-González, C. (2011) · Endocrine Practice · doi:10.4158/ep11167.or · Cited by 77
Effect of an Exercise Intervention on Gestational Diabetes Mellitus: A Randomized Controlled Trial
Nobles, C., Marcus, B. H., Stanek, E. J., Braun, B., Whitcomb, B. W., Solomon, C. G., Manson, J. E., Markenson, G., & Chasan-Taber, L. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000738 · Cited by 62
McCance, D. R. (2015) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2015.04.009 · Cited by 96
Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus
Nuzzo, A. M., Giuffrida, D., Moretti, L., Re, P., Grassi, G., Menato, G., & Rolfo, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-81785-5 · Cited by 72
National Diabetes Data Group vs Carpenter-Coustan criteria to diagnose gestational diabetes
Berggren, E. K., Boggess, K. A., Stuebe, A. M., & Jonsson Funk, M. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.06.026 · Cited by 66
“Proiding additional women with the ssociated nutritional counseling and elf-glucose monitoring may improve lycemic control and thus decrease aderse perinatal outcomes.(17) Gestational iabetes is a known risk factor for future ype 2 diabetes mellitus and related longerm poor health outcomes and may be ssociated with an…”
BackgroundHartling, L., Dryden, D. M., Guthrie, A., Muise, M., Vandermeer, B., & Donovan, L. (2014) · Diabetic Medicine · doi:10.1111/dme.12357 · Cited by 66
What is known and what remains unresolved regarding gestational diabetes mellitus (GDM)
Vince, K., Perković, P., & Matijević, R. (2020) · Journal of Perinatal Medicine · doi:10.1515/jpm-2020-0254 · Cited by 76
Maternal outcome of gestational diabetes mellitus
Beucher, G., de Lesegno, B. V., & Dreyfus, M. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.11.006 · Cited by 76
Boyle, K. E., Hwang, H., Janssen, R. C., DeVente, J., Barbour, L. A., Hernandez, T. L., Mandarino, L. J., Lappas, M., & Friedman, J. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106872 · Cited by 73
Genome-wide DNA methylation variation in maternal and cord blood of gestational diabetes population
Kang, J., Lee, C., Li, H., Hsu, K.-H., & Lin, S. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.034 · Cited by 73
Kaseva, N., Vääräsmäki, M., Matinolli, H., Sipola‐Leppänen, M., Tikanmäki, M., Heinonen, K., Lano, A., Wolke, D., Andersson, S., Järvelin, M., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.277 · Cited by 76
Shokry, E., Marchioro, L., Uhl, O., García-Bermúdez, M., García-Santos, J. A., Segura, M. T., Campoy, C., & Koletzko, B. V. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01291-z · Cited by 68
Mokkala, K., Vahlberg, T. J., Pellonperä, O., Houttu, N., Koivuniemi, E., & Laitinen, K. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz220 · Cited by 66
Barriers to completing oral glucose tolerance testing in women at risk of gestational diabetes
Lachmann, E. H., Fox, R. A., Dennison, R. A., Usher‐Smith, J. A., Meek, C. L., & Aiken, C. E. (2020) · Diabetic Medicine · doi:10.1111/dme.14292 · Cited by 65
Noctor, E., Crowe, C., Carmody, L. A., Saunders, J. A., Kirwan, B., O’Dea, A., Gillespie, P., Glynn, L. G., McGuire, B. E., O’Neill, C., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1260 · Cited by 65
Gestational diabetes mellitus: Major risk factors and pregnancy-related outcomes: A cohort study
Kouhkan, A., Najafi, L., Malek, M., Baradaran, H. R., Hosseini, R., Khajavi, A., & Khamseh, M. E. (2021) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v19i9.9715 · Cited by 88
An Update of Medical Nutrition Therapy in Gestational Diabetes Mellitus
Vasile, F. C., Preda, A., Ștefan, A. G., Vladu, I. M., Forțofoiu, M.-C., Clenciu, D., Gheorghe, I.-O., Forţofoiu, M., & Moța, M. (2021) · Journal of Diabetes Research · doi:10.1155/2021/5266919 · Cited by 77
First-trimester biochemical markers of placentation in screening for gestational diabetes mellitus
Syngelaki, A., Kotecha, R., Pastides, A., Wright, A., & Nicolaides, K. H. (2015) · Metabolism · doi:10.1016/j.metabol.2015.07.015 · Cited by 71
Moses, R. G., Casey, S., Quinn, E. G., Cleary, J. M., Tapsell, L. C., Milosavljevic, M., Petocz, P., & Brand-Miller, J. C. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.074138 · Cited by 78
Tagoma, A., Alnek, K., Kirss, A., Uibo, R., & Haller-Kikkatalo, K. (2018) · Gene · doi:10.1016/j.gene.2018.06.004 · Cited by 59
Boyle, D. I., Versace, V. L., Dunbar, J., Scheil, W., Janus, E. D., Oats, J. J. N., Skinner, T. C., Shih, S. T. F., O'Reilly, S. L., Sikaris, K. A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200832 · Cited by 66
Correa, P. J., Venegas, P., Palmeiro-Silva, Y. K., Albers, D., Rice, G. E., Roa, J., Cortez, J., Mönckeberg, M., Manuel Schepeler, S., Osorio, E., et al. (2018) · Journal of Perinatal Medicine · doi:10.1515/jpm-2018-0120 · Cited by 65
Huo, X., Li, J., Cao, Y.-F., Li, S.-N., Shao, P., Leng, J., Li, W., Liu, J., Yang, K., Ma, R. C. W., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00710 · Cited by 65
Laurie, J. G., & McIntyre, H. D. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17249387 · Cited by 65
Trujillo, J., Vigo, A., Duncan, B. B., Falavigna, M., Wendland, E. M., Campos, M. A., & Schmidt, M. I. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.02.007 · Cited by 64
“c Any one value reaching alternative (higher) cut-offs (fasting, 1 h or 2 h values during a 2 h 75 g OGTT) [9,14].”
BackgroundMethodInfluentialObjectively measured sleep duration and hyperglycemia in pregnancy
Herring, S. J., Nelson, D. B., Pien, G. W., Homko, C., Goetzl, L. M., Davey, A., & Foster, G. D. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2013.07.018 · Cited by 64
Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin?
Saleh, H. S., Abdelsalam, W. A., Mowafy, H. E., & Abd ElHameid, A. A. (2016) · International Journal of Reproductive Medicine · doi:10.1155/2016/3480629 · Cited by 61
“The hyperglycemic environment intrauterine influences children later in life [5].”
BackgroundFirst trimester biomarkers for prediction of gestational diabetes mellitus
Tenenbaum-Gavish, K., Sharabi‐Nov, A., Binyamin, D., Møller, H. J., Danon, D., Rothman, L., Hadar, E., Idelson, A., Vogel, I., Koren, O., et al. (2020) · Placenta · doi:10.1016/j.placenta.2020.08.020 · Cited by 72
Exercise as a Therapeutic Intervention in Gestational Diabetes Mellitus
Δίπλα, Κ., Zafeiridis, A., Mintziori, G., Boutou, A., Goulis, D. G., & Hackney, A. C. (2021) · Endocrines · doi:10.3390/endocrines2020007 · Cited by 66
“Gestational Diabetes Mellitus (GDM) is a distinct subcategory of Diabetes Mellitus, defined as any degree of glucose intolerance with onset or first recognition during pregnancy [1,2].”
BackgroundVerde, M. L., Torella, M., Riemma, G., Narciso, G., Iavarone, I., Gliubizzi, L., Palma, M., Morlando, M., Colacurci, N., & FRANCISCIS, P. D. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15205 · Cited by 68
“GDM is usually diagnosed following the screening made with the one-step procedure with a 75-g, 2-h oral glucose tolerance test (OGTT).(4) The 75-g, 2-h OGTT was administered at 16–18 weeks’ gestation in high-risk GDM pregnancies (previous GDM, first-trimester fasting glucose 100–125 mg/dL, BMI ≥30 kg/m(2)), while OGTT…”
MethodDennedy, M. C., Avalos, G., O'Reilly, M. W., O'Sullivan, E. P., Gaffney, G., & Dunne, F. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2674 · Cited by 63
“We confirm the findings of previous analyses addressing independent effects of maternal BMI on adverse obstetric outcomes (8, 9) but with the application of stricter criteria for glucose tolerance (10, 11).”
MethodResultThe risk of large for gestational age across increasing categories of pregnancy glycemia
Ehrlich, S. F., Crites, Y. M., Hedderson, M. M., Darbinian, J. A., & Ferrara, A. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.10.907 · Cited by 63
Risk factors of gestational diabetes mellitus recurrence: a meta-analysis
Schwartz, N., Nachum, Z., & Green, M. S. (2016) · Endocrine · doi:10.1007/s12020-016-0922-9 · Cited by 72
Prediction models for the risk of gestational diabetes: a systematic review
Lamain – de Ruiter, M., Kwee, A., Naaktgeboren, C. A., Franx, A., Moons, K. G. M., & Koster, M. P. H. (2017) · Diagnostic and Prognostic Research · doi:10.1186/s41512-016-0005-7 · Cited by 62
“There is an international guideline for diagnostic strategies and criteria for GDM [42], but international implementation is hampered by the ongoing debate on a “gold standard.”
Screening and Management of Gestational Diabetes Mellitus after Bariatric Surgery
Benhalima, K., Minschart, C., Ceulemans, D., Bogaerts, A., der Schueren, B. V., Mathieu, C., & Devlieger, R. (2018) · Nutrients · doi:10.3390/nu10101479 · Cited by 72
Li, S., Hou, Y., Yan, X., Wang, Y., Shi, C., Wu, X., Liu, H., Zhang, L., Zhang, X., Liu, J., et al. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12899 · Cited by 71
Zhang, X., Gong, Y., Corte, K. W. D., Yu, D., Xue, H., Shan, S., Tian, G., Liang, Y., Zhang, J., He, F., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.03.041 · Cited by 72
Benhalima, K., Mathieu, C., Van Assche, A., Damm, P., Devlieger, R., Mahmood, T., & Dunne, F. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.04.003 · Cited by 63
Gestational Diabetes Mellitus: NICE for the U.S.?
Simmons, D., McElduff, A., McIntyre, H. D., & Elrishi, M. (2010) · Diabetes Care · doi:10.2337/dc09-1376 · Cited by 61
Bilous, R. W., Jacklin, P., Maresh, M., & Sacks, D. A. (2021) · Diabetes Care · doi:10.2337/dc20-2941 · Cited by 72
Song, S., Zhang, Y., Qiao, X., Duo, Y., Xu, J., Peng, Z., Zhang, J., Chen, Y., Nie, X., Sun, Q., et al. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13905 · Cited by 69
González-Plaza, E., Bellart, J., Arranz, Á., Luján‐Barroso, L., Crespo-Mirasol, E., & Seguranyes, G. (2022) · JMIR mhealth and uhealth · doi:10.2196/28886 · Cited by 70
Dedov, I. I., Krasnopol'skiy, V. I., & Sukhikh, G. T. (2012) · Diabetes Mellitus · doi:10.14341/2072-0351-5531 · Cited by 63
Testing for Gestational Diabetes Mellitus in Australia
Nankervis, A., McIntyre, H. D., Moses, R. G., Ross, G. P., & Callaway, L. K. (2013) · Diabetes Care · doi:10.2337/dc12-2345 · Cited by 63
Nielsen, K. K., Courten, M. D., & Kapur, A. (2012) · Global Health Action · doi:10.3402/gha.v5i0.17277 · Cited by 64
“all pregnant women to be screened for GDM (35).”
BackgroundMethodInfluentialHung, T.-H., & Hsieh, T.-T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122261 · Cited by 61
“Following the release of the HAPO Study, the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) made recommendations in an attempt to reach international uniformity and consensus on the diagnostic criteria for GDM with respect to its value in predicting adverse pregnancy outcomes [5].”
MethodInfluentialPustozerov, E., Popova, P., Tkachuk, A., Bolotko, Y., Yuldashev, Z. M., & Grineva, E. N. (2018) · JMIR mhealth and uhealth · doi:10.2196/mhealth.9236 · Cited by 67
Nakanishi, H., Suenaga, H., Uchiyama, A., Kono, Y., & Kusuda, S. (2018) · Journal of Perinatology · doi:10.1038/s41372-018-0061-7 · Cited by 69
Yuan, X., Hu, H., Zhang, M., Long, W., Liu, J., Jiang, J. W., & Yu, B. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0360-9 · Cited by 63
Maternal obesity and dyslipidemia associated with gestational diabetes mellitus (GDM)
O’Malley, E. G., Reynolds, C. M. E., Killalea, A., O’Kelly, R., Sheehan, S. R., & Turner, M. J. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.01.007 · Cited by 62
Holder, T., Giannini, C., Santoro, N., Pierpont, B., Shaw, M., Duran, E., Caprio, S., & Weiss, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3345-2 · Cited by 62
“7% exposure rate to GDM, which is consistent with a contemporary rate of 18% reported by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) [24, 25].”
MethodResultInfluentialDifferent methods and settings for glucose monitoring for gestational diabetes during pregnancy
Raman, P., Shepherd, E., Dowswell, T., Middleton, P., & Crowther, C. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011069.pub2 · Cited by 62
Hivert, M.-F., White, F., Allard, C., James, K., Majid, S., Aguet, F., Ardlie, K. G., Florez, J. C., Edlow, A. G., Bouchard, L., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02936-5 · Cited by 62
Zhou, X., Chen, R., Zhong, C., Wu, J., Li, X., Li, Q., Cui, W., Yi, N., Xiao, M., Yin, H., et al. (2018) · British Journal of Nutrition · doi:10.1017/s0007114518002453 · Cited by 62
Lee, K. W., Ching, S. M., Devaraj, N. K., Chong, S. C., Lim, S. Y., Loh, H. C., & Hamid, H. A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17113767 · Cited by 69
Perak, A. M., Lancki, N., Kuang, A., Labarthe, D. R., Allen, N. B., Shah, S. H., Lowe, L. P., Grobman, W. A., Scholtens, D. M., Lloyd-Jones, D. M., et al. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.07.053 · Cited by 63
Comparing IADPSG and NICE Diagnostic Criteria for GDM in Predicting Adverse Pregnancy Outcomes
He, Y., Ronald, C. W., McIntyre, D. H., Sacks, D. A., LOWE, J. M., Catalano, P. M., & Tam, W. H. (2022) · Diabetes Care · doi:10.2337/dc22-0579 · Cited by 66
The IDF Diabetes Atlas methodology for estimating global prevalence of hyperglycaemia in pregnancy
Linnenkamp, U., Guariguata, L., Beagley, J., Whiting, D. R., & Cho, N. H. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.004 · Cited by 72
Is oxidative stress induced by iron status associated with gestational diabetes mellitus?
Zein, S., Rachidi, S., & Hininger‐Favier, I. (2013) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2013.09.009 · Cited by 65
Bhavadharini, B., Mahalakshmi, M. M., Maheswari, K., Kalaiyarasi, G., Anjana, R. M., Deepa, M., Ranjani, H., Priya, M., Uma, R., Sriram, U., et al. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0761-9 · Cited by 63
Screening and management of gestational diabetes
Benhalima, K., Devlieger, R., & Assche, A. V. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.07.026 · Cited by 78
Eleftheriades, M. I., Papastefanou, I., Lambrinoudaki, I. V., Kappou, D., Lavranos, D., Akalestos, A., Souka, A. P., Pervanidou, P., Hassiakos, D., & Chrousos, G. P. (2014) · Metabolism · doi:10.1016/j.metabol.2014.07.016 · Cited by 68
“Various GDM screening protocols include universal screening or screening upon specific risk factors [9–11].”
BackgroundInfluentialSocio-demographic risk factors of Gestational Diabetes Mellitus
Khan, R., Ali, K., & Khan, Z. (2013) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.293.3629 · Cited by 57
Shao, B., Mo, M., Xin, X., Jiang, W., Wu, J., Huang, M., Wang, S., Muyiduli, X., Si, S., Shen, Y., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.10.015 · Cited by 58
Sun, T., Meng, F., Zhao, H., Yang, M., Zhang, R., Yu, Z., Huang, X., Ding, H., Liu, J., & Zang, S. (2020) · Diabetes · doi:10.2337/db19-0976 · Cited by 69
A Medically Supervised Pregnancy Exercise Intervention in Obese Women: A Randomized Controlled Trial
Daly, N., Farren, M., McKeating, A., O'Kelly, R., Stapleton, M., & Turner, M. J. (2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002267 · Cited by 61
Sun, Z., Pan, X., Li, X., Jiang, L., Hu, P., Wang, Y., Ye, Y., Wu, P., Zhao, B., Xu, J., et al. (2023) · Advanced Science · doi:10.1002/advs.202205289 · Cited by 67
Wu, P., Wang, Y., Ye, Y., Yang, X., Huang, Y., Ye, Y., Lai, Y., Ouyang, J., Wu, L., Xu, J., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02818-6 · Cited by 72
Stillbirth in the Pregnancy Complicated by Diabetes
Starikov, R. S., Dudley, D. J., & Reddy, U. M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0580-y · Cited by 69
Metadata
- Authors
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Corresponding author
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-03-01
- Volume
- 33
- Issue
- 3
- Pages
- 676-682
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2827530
- OpenAlex
- W2616235706
- Cited by
- 5,390
- References
- 56
- Citations by year
- 2026: 314 · 2025: 377 · 2024: 446 · 2023: 423 · 2022: 494 · 2021: 507 · 2020: 425 · 2019: 350 · 2018: 367 · 2017: 297 · 2016: 274 · 2015: 296 · 2014: 235 · 2013: 203 · 2012: 167
- FWCI
- 250.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- American Diabetes Association
- Kaiser Permanente
- National Institute of Child Health and Human Development (R01‐HD34242, R01-HD-34243)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD-34243, R01-HD-34242, R01HD034242, R01HD034243)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, hyperglycemia in pregnancy, IADPSG criteria, perinatal outcomes, maternal glycemia, diagnostic thresholds
- MeSH terms
- Female, Health Planning Guidelines, Humans, Hyperglycemia, International Cooperation, Pregnancy, Pregnancy Complications, Pregnancy in Diabetics, Societies, Medical, Diabetes, Gestational, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.